Norgine Expands Rare Disease Portfolio with Theravia Acquisition
April 15, 2025
Transaction further establishes Norgine’s position as a partner of choice for commercialising rare and specialty pharmaceuticals in Europe Norgine and Theravia announced that they have entered into